Radioactive Shrimp, Ozempic Allegations: The MedPage Today Culture Awards
(MedPage Today) — We’ve nominated medicine’s biggest culture makers and moments of 2025, it’s your turn to vote
STAT+: Pharmalittle: We’re reading about the Pfizer-Novo battle for Metsera, a Lilly obesity drug, and more
Top of the morning to you, and a fine one it is. Despite howling winds lashing the Pharmalot campus, the skies are clear and sunny, and the official mascots are napping here and there. As for us, we are engaged in the usual rituals, starting with firing up the coffee kettle — our choice today […]
Regulation of therapeutic protein release in response to circadian biomarkers
Nature Communications, Published online: 06 November 2025; doi:10.1038/s41467-025-64761-9 Circadian clocks integrate external environmental and internal physiological cues to generate oscillations of secreted endocrine signals. Here the authors build a melatonin-based circadian biomarker-driven gene switch in mammalian cells for type-2 diabetes treatment by oscillatory GLP-1 release.
‘BeanTok’ trend goes viral with wild gut health promises — here’s what experts say
A new TikTok trend promising better gut health is gaining steam — but experts caution this viral movement may come with some unpleasant side effects. In an online community known as “BeanTok,” users are hyping two cups of beans a day as the next big wellness trend. From black beans to lentils and chickpeas, videos […]
GLP-1 drugs: a perfect-storm game-changer for food or just a crosswind?
There are many unknowns as to the real or potential hit on packaged foods manufacturers in both the short and longer term. The post GLP-1 drugs: a perfect-storm game-changer for food or just a crosswind? appeared first on Just Food.
Trump, long fixated on ‘fat drug,’ to announce deal to lower its price
The president has cited the high cost of GLP-1 drugs, which help with weight loss, as his go-to example in his push to reduce U.S. drug prices.
Health Insurance Open Enrollment: Most Americans are Satisfied with Coverage, But 73% Delay Care Due to Costs
Survey identifies confusion over coverage for GLP-1 drugs for weight loss, interest in AI to support enrollment, and support for ICHRA-style coverage AUSTIN, Texas, Nov. 6, 2025 /PRNewswire/ — eHealth (Nasdaq: EHTH), a leading health insurance marketplace, today released new survey…
Trump, long fixated on ‘fat drug,’ to announce deal to lower its price
The president has cited the high cost of GLP-1 drugs, which help with weight loss, as his go-to example in his push to reduce U.S. drug prices.
Costs for Zepbound, Wegovy Could Drop Soon: What to Know
The White House is in discussions with the makers of weight loss drugs Wegovy and Zepbound to drastically lower prices, NBC News has learned. The prices could drop from an average price of $1,300 a month to $150 a month, according to sources familiar with the plan. It remains unclear who would be eligible. NBC’s Vicky Nguyen joins TODAY to break down the details.
Top food tech trends for 2026
As sustainability wanes, other trends – hybrid meat, GLP-1-friendly products, even clean water – come to the fore. But investment in food tech overall is becoming more discerning, asking for a greater guarantee of profitability before investment.